[ad_1]
It is true that the approval of this vaccine continues with its drawbacks. Outraged by the lower-than-promised quantities of the upcoming vaccine, Brussels announced the introduction of an export control scheme. If Brussels believes that pharmacists are clever, they will not be allowed to abandon the European vaccine.
Yesterday, the hospitals in Madrid, and today in Barcelona, announced that they are blocking the vaccination of the population against the coronavirus. Vaccine shipments from Pfizer and Moderna are delayed, so that in Catalonia alone, 10,000 people cannot receive a second vaccine. It is estimated that at the current rate, up to 14 percent of the country’s population will be vaccinated in the summer, although three out of every four Spaniards are expected to be vaccinated in the fall.
“We stopped taking the first dose of Pfizer due to a supply interruption. We are waiting for the situation to return to normal to finish vaccinating all staff,” says Dr. San Pau, specialist at the Dr. Rafael Padro.
The European Union hopes that the approval of AstraZeneca today will improve the situation in vaccination centers in Europe. However, AstraZeneca has announced that it will deliver more than € 80 million to the Community in the near future due to problems at its plants in Belgium and the Netherlands. promised doses of the vaccine, and only 31 million.
Just yesterday, when Brussels demanded that UK factories cover the deficit, the drugmaker refused to do so. Outraged, the European Commission today unveiled the contract with AstraZeneca, once again demanding that it fulfill its obligations to supply the vaccine from UK factories.
“Transparency and accountability are key to gaining the trust of European citizens and ensuring they have confidence in the efficacy of the vaccine purchased by the European Union,” said Eric Memer, spokesman for the European Commission.
Euroblock members who have not received the promised vaccine are increasingly talking about blocking the export of the European-produced vaccine to the UK if it turns out that the vaccines produced in Belgium and the Netherlands are shipped to that country.
“The countries of the European Union have invested together in the development of the vaccine and now hope to get a return. We are not saying ‘Europe first’, we just want to get our fair share,” said German Health Minister Jens Spahn.
Hungary is tackling the vaccination delay in its own way. Last week, Budapest exceptionally approved the Russian-made Sputnik V vaccine and today the Chinese Sinopharm vaccine.
And as vaccine companies try to establish themselves in new markets, American biotech company Novavax has announced the results of another vaccine that is currently being tested. It has been tested on almost 96% of the 15,000 UK volunteers. efficacy against the initial coronavirus strain and nearly 86% resistance to the most contagious British mutation.
However, prior to the strain that started to spread in South Africa, the efficiency is only 60 percent. The European Union does not yet have plans to buy this vaccine.
[ad_2]
